David B. Roberts - 29 May 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Reporting relationship: President and Director, Director
Issuer ticker: LMAT
Reported as of: 29 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jun 2025, 16:17:14 UTC
Prior SEC filing: 31 Mar 2025
Next SEC filing: 10 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Nathan Ulrich

Key filing fact

David B. Roberts filed Form 4 for LEMAITRE VASCULAR INC (LMAT) on 02 Jun 2025.

Key facts

This page summarizes David B. Roberts's Form 4 filing for LEMAITRE VASCULAR INC (LMAT).
8 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 02 Jun 2025, 16:17.

Change

Previous filing in this sequence was filed on 31 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001365731 Primary reporting owner

Roberts David B

Relationship: President and Director, Director
Address: C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON
Signature: /s/ Nathan Ulrich
Signature date: 02 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +1
Change %: +5.5%
Price: $0.000000
Shares after: 16
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1
Exercise price
Footnotes: F1

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +2
Change %: +7.3%
Price: $0.000000
Shares after: 24
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2
Exercise price
Footnotes: F2

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +3
Change %: +12%
Price: $0.000000
Shares after: 32
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3
Exercise price
Footnotes: F3

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +3
Change %: +12%
Price: $0.000000
Shares after: 31
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3
Exercise price
Footnotes: F4

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +4
Change %: +24%
Price: $0.000000
Shares after: 22
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4
Exercise price
Footnotes: F5

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +5
Change %: +29%
Price: $0.000000
Shares after: 23
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5
Exercise price
Footnotes: F6

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +3
Change %: +104%
Price: $0.000000
Shares after: 6
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3
Exercise price
Footnotes: F7

LMAT transaction Derivative

Dividend Equivalent Rights

Award

Transaction value: $0
Shares: +0
Change %: +103%
Price: $0.000000
Shares after: 1
Date: 29 May 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 0
Exercise price
Footnotes: F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F2

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F3

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F4

These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F5

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F6

These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F7

These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Footnote F8

These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.